Previous issue | Volume 89 | ESPE2018 | Next issue

57th Annual ESPE

Athens, Greece
27 Sep 2018 - 29 Sep 2018

Card image cap
ESPE 2018 57th European Society for Paediatric Endocrinology Annual Meeting 27-29 September 2018 Athens, Greece

Free Communications

Bone, Growth Plate & Mineral Metabolism 1

Burosumab, a Fully Human anti-FGF23 Monoclonal Antibody, for X-linked Hypophosphatemia (XLH): Sustained Improvement in two Phase 2 Trials in Affected Children 1-12 years old
aAPHP Hôpital Bicêtre Paris Sud, Paris, USA; bGreat Ormond Street Hospital, London, UK; cShriners Hospitals for Children, St. Louis, Missouri, USA; dIndiana University School of Medicine, Indianapolis, Indiana, USA; eUniversity of California, San Francisco, California, USA; fUniversity of Groningen, Groningen, Netherlands; gBirmingham Children’s Hospital, Birmingham, UK; hRoyal Manchester Children’s Hospital, Manchester, UK; iUltragenyx Pharmaceutical Inc., Novato, California, USA; jYale School of Medicine, New Haven, Connecticut, USA
hrp0089fc2.1
Whole Genome Sequencing Reveals Novel Intragenic Deletions of GNAS as Causes of Pseudohypoparathyroidism Type 1a
aThe Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; bSpectrum Health, Grand Rapids, Michigan, USA
hrp0089fc2.2
Clinical Course of Hypoparathyroidism in Patients with APECED (APS1)
aChildren’s Hospital, University Hospital of Helsinki and University of Helsinki, Helsinki, Finland; bFolkhälsan Research Center, Biomedicum, Helsinki, Finland
hrp0089fc2.3
Diagnostic Performance of Artificial Neural Network-based TW3 Skeletal Maturity Assessment
aThe children’s Hospital of Zhejiang University School of Medicine, Hangzhou, China; bShanghai Yitu Network Technology Co. LTD., Shanghai, China
hrp0089fc2.4
Radial ESWT Stimulates Longitudinal Bone Growth in Cultured Rat Fetal Metatarsal Bones
aPaediatric Orthopaedics, Christian Medical College, Vellore, India; bPaediatric Endocrinology, Department of Women’s and Children’s Heath, Karolinska Institutet, Stockholm, Sweden; cCenter for Stem Cell Research, Christian Medical College, Vellore, India
hrp0089fc2.5
Final Height is Negatively Related to Disease Burden in Mitochondrial Disease
aDepartment of Paediatric Endocrinology, Great North Children’s Hospital, Royal Victoria Infirmary, Newcastle Upon Tyne, UK; bWellcome Centre for Mitochondrial Research, Institute of Neuroscience, 4th Floor Cookson Building, Medical School, Framlington Place, Newcastle University, Newcastle Upon Tyne, UK; cInstitute of Genetic Medicine, Newcastle University c/o Office Block 1. Floor 3, Royal Victoria Infirmary, Newcastle Upon Tyne, UK
hrp0089fc2.6